Unterehmen auf Watchlist setzen
ASP Isotopes
ISIN: US00218A1051
WKN: A3DRP8
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

ASP Isotopes · ISIN: US00218A1051 · PR Newswire (ID: 20241220LA84858)
20 Dezember 2024 10:00PM

ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit


LOS ANGELES, Dec. 20, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against ASP Isotopes Inc. ("ASP Isotopes" or the "Company") (NASDAQ: ASPI).

Class Period: October 30, 2024November 26, 2024

Lead Plaintiff Deadline: February 3, 2025

If you wish to serve as lead plaintiff of the ASP Isotopes lawsuit, you can submit your contact information at www.glancylaw.com/cases/ASP-Isotopes-Inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors: (1) the Company overstated the potential effectiveness of its enrichment technology; (2) the Company overstated the development potential of its high assay low-enriched uranium facility; (3) the Company overstated the Company's nuclear fuels operating segment results; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Follow us for updates on LinkedIn, Twitter, or Facebook.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles

Charles Linehan, 310-201-9150 or 888-773-9224

shareholders@glancylaw.com

www.glancylaw.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/aspi-investors-have-opportunity-to-lead-asp-isotopes-inc-securities-fraud-lawsuit-302337573.html

SOURCE Glancy Prongay & Murray LLP

Visuelle Wertentwicklung / Kursverlauf · ASP Isotopes
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2024
PR Newswire
Kontakt:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942